Research Paper Volume 16, Issue 17 pp 12335—12345
Treatment of tumor-associated macrophages with PD-1 monoclonal antibodies affects vascular generation in cervical cancer via the PD-1/IRE1α/SHP2/HIF1α signaling pathway
Figure 3. Impact of PD-1 monoclonal antibodies in TAMs on the migration ability of cervical cancer cells. (A) Wound healing results and cell spacing statistics of Hela cells and C33A cells; (B) Transwell migration assay results plot and statistics on the number of migrating cells for Hela cells and C33A cells. Data were expressed as mean±SD. *P<0.05; **P<0.01; nsP>0.05.